Your session is about to expire
← Back to Search
Xanthohumol for Healthy Subjects (XMaS Trial)
XMaS Trial Summary
This trial tests if a plant-based compound is safe and tolerated by people and how it's processed by the body.
XMaS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowXMaS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.XMaS Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I have not experienced any recent injuries in the past 2 weeks.I am currently on or recently took blood thinners.I am currently on or recently took antibiotics, antiparasitics, or antifungals.I can collect stool samples at home twice a week.I have been on IV nutrition support recently.I regularly use pain relievers like ibuprofen or aspirin more than once a week.I am currently receiving UV therapy for a skin condition.I am between 21 and 50 years old.I have used prescription opioids in the last 3 months.I am not pregnant, breastfeeding, or planning to become pregnant soon.I am willing to fast for 10-12 hours and have my blood drawn twice a week.You exercise really hard for more than 6 hours every week.You drink more than one small beer per day.I haven't been hospitalized in the last 3 months, except for planned procedures.You have been drinking more than 2 alcoholic beverages per day, more than 14 per week, or more than 4 in a single day within the past month.I am willing to take a dietary supplement for 8 weeks.I do not have any chronic diseases like diabetes, heart issues, or uncontrolled high blood pressure.I have used prescription corticosteroids in the last 3 months.I haven't started or changed any medications or supplements in the last 30 days.I am not currently taking any prescription medications, including birth control pills.I have not had any gastrointestinal surgery in the last 3 months.You have used illegal drugs in the past month, such as cocaine, PCP, or methamphetamine.I have been taking supplements like turmeric or fish oil recently.I haven't had a serious infection or been on antibiotics in the last 2 weeks.
- Group 1: Xanthohumol
- Group 2: Placebo oral capsule
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are persons aged 35 or older being included in the experiment?
"This medical trial is accepting patients who are between 21 and 50 years of age."
Has Xanthohumol been investigated in other scientific research?
"At present, there is one clinical trial in progress looking into the potential of Xanthohumol. None are at Phase 3 yet; however, all studies concerning this compound originate from Portland, Oregon with a single location running tests for it."
Does Xanthohumol pose any health risks to humans?
"The safety of Xanthohumol has been tentatively assessed and given a rating of 1 due to the relatively nascent stage (Phase 1) in which the drug currently resides. This means that there is limited data available with regards to both its efficacy and safety."
What is the capacity of this clinical trial and how many participants are currently enrolled?
"Unfortunately, this clinical trial has concluded its recruitment activities. It was initially posted on August 12th 2019 and last updated on March 22nd 2023. If you're looking for alternative trials, 831 of them are presently accepting healthy participants and 1 is seeking those with Xanthohumol experience."
Are individuals still being enrolled in this experiment?
"According to the clinicaltrials.gov website, this particular trial is no longer actively seeking patients for enrollment; it was initially posted on August 12th 2019 with its last update occurring March 22nd 2023. Fortunately, there are 832 other trials that presently require participants."
What aims does this research endeavor hope to accomplish?
"The primary measure of this trial's success will be the observed change in Plasma Inflammatory Markers at intervals of Baseline, 2 weeks, 4 weeks, 6 weeks and 8 weeks. Secondary outcomes incorporate Complete Blood Count Abnormals (i.e., number of participants with an abnormal value compared to the total quantity), % new abnormals if any such values are noted according to Quest Diagnostics criteria, Mean Corpuscular Hemoglobin mean changes from baseline over time period specified earlier and finally Mean Corpuscular Volume calculated similarly as described before."
For whom is this investigation accessible?
"The trial is open to applicants aged 21-50 who meet healthy subject criteria. A total of 30 participants are being accepted into the study."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger